Compartir
The Problem of Alzheimer'S: How Science, Culture, and Politics Turned a Rare Disease Into a Crisis and What we can do About it (en Inglés)
Jason Karlawish
(Autor)
·
St. Martin's Griffin
· Tapa Blanda
The Problem of Alzheimer'S: How Science, Culture, and Politics Turned a Rare Disease Into a Crisis and What we can do About it (en Inglés) - Karlawish, Jason
$ 15.19
$ 18.99
Ahorras: $ 3.80
Elige la lista en la que quieres agregar tu producto o crea una nueva lista
✓ Producto agregado correctamente a la lista de deseos.
Ir a Mis ListasSe enviará desde nuestra bodega entre el
Lunes 01 de Julio y el
Martes 02 de Julio.
Lo recibirás en cualquier lugar de Estados Unidos entre 1 y 3 días hábiles luego del envío.
Reseña del libro "The Problem of Alzheimer'S: How Science, Culture, and Politics Turned a Rare Disease Into a Crisis and What we can do About it (en Inglés)"
A definitive and compelling book on one of today's most prevalent illnesses. In 2020, an estimated 5.8 million Americans had Alzheimer's, and more than half a million died because of the disease and its devastating complications. 16 million caregivers are responsible for paying as much as half of the $226 billion annual costs of their care. As more people live beyond their seventies and eighties, the number of patients will rise to an estimated 13.8 million by 2050. Part case studies, part meditation on the past, present and future of the disease, The Problem of Alzheimer's traces Alzheimer's from its beginnings to its recognition as a crisis. While it is an unambiguous account of decades of missed opportunities and our health care systems' failures to take action, it tells the story of the biomedical breakthroughs that may allow Alzheimer's to finally be prevented and treated by medicine and also presents an argument for how we can live with dementia: the ways patients can reclaim their autonomy and redefine their sense of self, how families can support their loved ones, and the innovative reforms we can make as a society that would give caregivers and patients better quality of life. Rich in science, history, and characters, The Problem of Alzheimer's takes us inside laboratories, patients' homes, caregivers' support groups, progressive care communities, and Jason Karlawish's own practice at the Penn Memory Center. It also includes a new epilogue recounting the FDA's surprising 2021 approval of the controversial Alzheimer's drug Aduhelm, the astonishing aftermath, and how these unique events explain the enduring problem of Alzheimer's.
